Preclinical models enabling drug discovery for receptor-mediated transcytosis research
10 Sept 2026
Preclinical Models
- What preclinical models are currently being used to support drug discovery in receptor-mediated transcytosis research?
- How effectively do existing models reflect the biological mechanisms relevant to receptor-mediated transcytosis?
- What are the key gaps and limitations in the current preclinical model landscape?
- How can preclinical models be improved to support the development of next-generation targets?
- What capabilities will be required to prepare for future advances in receptor-mediated transcytosis research?
Industry Expert
